Back to catalogue
№ 105 24 filings · 2021-06-24 → 2025-09-26

DEKEL AGRI-VISION PLC

DKL
Food, Beverage and Tobacco Market cap £4.54m Overall fit 90 /1000

Zero AI exposure (West African palm/cashew processor), only modest operating leverage in the cashew segment, fragile balance sheet with recent going-concern flags and 76% dilution at 0.55p. Fails all three pillars of the investor's framework simultaneously, hence low-200s score despite trading roughly at fair value.

Fair value range 0p–1p Mid case · £4.70m
Absolute upside +3.6% vs current market cap
Conviction 2/5 confidence in fair call
Supports the call
  • Clear segment disclosure for palm and cashew
  • Multi-year historical operating data anchors palm baseline
  • Recent debt restructuring terms quantified in filings
Limits the call
  • Highly levered: small EBITDA changes swing equity value disproportionately
  • Repeated cashew execution slippage makes FY26+ forecasts speculative
Methodology

EV/EBITDA SOTP with net-debt deduction

In one line · bull case

Palm-oil cash cow plus a finally-inflecting cashew operation, restructured debt, and a balance sheet that no longer needs rescuing — but priced at £5m for good reason.

In one line · biggest risk

Net debt of €31m on €5–6m EBITDA leaves equity as a thin option that another bad cashew quarter or 15% CPO drop could wipe out.

Drivers
AI beneficiary 3 /100
West African palm oil and cashew processor with no AI exposure of any kind.
Operating leverage 45 /100
Palm side is variable-cost dominated (66% fruit cost); cashew mill has real fixed-cost leverage but is sub-scale and unproven.
Earnings vs expectations 35 /100
Palm broadly meets; cashew has missed production/EBITDA milestones in 2022, 2023 and 2024.
Growth momentum 55 /100
H1 25 group revenue +24.5%, EBITDA +10.7%, cashew approaching maiden positive EBITDA — genuinely improving but off a low base.
Moat 15 /100
Commodity processor with local smallholder relationships but no structural moat.
Earnings quality 30 /100
Going-concern language, related-party loans, repeated equity dilution; cash conversion adequate at operating level but heavy finance costs.
Management quality 30 /100
Long-tenured but track record of slippage and deeply dilutive rescue financings at 0.55p.
Cyclicality 80 /100
Highly cyclical: CPO and PKO prices swing 30–60% YoY and dominate margin.
Leverage 85 /100
Gross debt €32m vs equity €7.5m; working capital deficit €9.5m; recurring restructurings.
Value-trap signals · 7
  • Going-concern language in FY24 audited accounts
  • Working capital deficit of €9.5m at H1 25
  • Three rounds of debt restructuring across 18 months
  • Equity placement at 0.55p in June 2025 (~76% dilution including CEO debt conversion)
  • Repeated cashew project slippage 2022–2024
  • Customer concentration: single customer 57% of FY24 revenue
  • CEO related-party loan/equity conversion at placing price

DEKEL AGRI-VISION PLC (DKL) — Investment Research Note

Executive summary

Dekel Agri-Vision is a sub-£10m AIM-listed West African agribusiness operating a 60,000tpa crude palm oil ("CPO") mill in Ayenouan, Côte d'Ivoire and ramping a cashew processing plant in Tiebissou. Across the period covered (FY20–H1 25) Group EBITDA has hovered around €2.5–3.1m on €20–38m revenues, with profitability dominated by volatile CPO/PKO prices and an unprofitable, repeatedly delayed cashew project that only now is approaching maiden positive EBITDA. The single most important point for valuation is that this is a highly leveraged commodity processor (net debt ~€31m vs. equity ~€7.5m) operating with a working-capital deficit of €9.5m and a debt structure that has just been restructured for the third time — equity is effectively a thin sliver of optionality on the cashew ramp and palm-oil prices.

Fair value estimate

Methodology: EV/EBITDA sum-of-the-parts cross-checked with residual equity to net debt.

  • FY25E Group EBITDA: €5–6m (€3.1m H1 25 + cashew inflection + seasonal H2; per Sep-2025 interim).
  • Apply 5–7x EV/EBITDA (typical for commodity-processing small caps in EM, discounted for leverage/governance) → EV €25–42m.
  • Subtract net debt of ~€31m (€32.3m gross debt - €1.3m cash, per H1 25 balance sheet, pro forma for ~£2.2m placing).
  • Residual equity: €-6m to €+11m (call it €0–10m, or roughly £0–9m).
  • Post-raise share count is ~1,174m (560m existing + 426m placing + 188m debt-for-equity conversion at 0.55p, per 2025-09 and 2025-06 filings).

Fair value per share range: 0.0p – 0.8p (midpoint ~0.4p) Implied market cap range: £0m – £9m (mid ~£4.7m)

Versus the disclosed £5.1m market cap, this gives a range from -100% downside to ~+75% upside, with a central case very close to today's price. View: fair, with a wide range driven by leverage gearing.

Sector context

  • ICB sector confirmed: Consumer Staples / Food, Beverage & Tobacco (Food Producers).
  • Quality/growth/leverage profile is well below typical sector peers: micro-cap, single-country EM commodity exposure, high leverage, recent debt restructuring, recurring equity dilution at deep discounts.
  • Listed peer comparators (palm oil / West Africa agri): R.E.A. Holdings (RE.), Anglo-Eastern Plantations (AEP), MP Evans (MPE). All of these are materially larger, less levered and with better disclosure than DKL.

Investment thesis (3 bullets)

  1. Cashew turnaround inflection: H1 25 revenue +150% with RCN throughput +269% and EBITDA loss narrowed from €0.9m to €0.2m, with maiden full-year positive EBITDA targeted for FY25 2025-09 interim, 2025-06 FY24 finals.
  2. CPO/PKO pricing tailwind: H1 25 average CPO €963/t (+25% YoY) and PKO €1,266/t (+58% YoY), continuing into multi-year highs and supporting the resilient palm-oil EBITDA contribution (€3.3m H1 25) 2025-09 interim.
  3. Debt restructure substantially complete: NSIA, BIDC and AgDevCo facilities (€10.7m combined) now rephased with 18–24-month principal grace periods; Hudson €13.6m bond expected to follow in Q4 25; combined with the £3.3m equity raise this materially de-risks the next 24 months 2025-09 interim, 2025-06 FY24 finals.

Key risks (3 bullets)

  1. Balance-sheet fragility: Working capital deficit of €9.5m at H1 25, gross debt €32.3m vs. equity €7.5m, accumulated deficit €26.7m, and going-concern language in both the audited FY24 and H1 25 statements. A weak CPO season or further cashew slippage forces another rescue raise 2025-09 interim, 2025-06 FY24 finals.
  2. Repeated cashew execution failures: Plant has now been "about to ramp" since 2022; 2023 was meant to be commercial production; 2024 had supplier/peeling-shelling equipment failures; FY24 cashew EBITDA was still -€1.3m. Track record of guidance slippage is long and consistent 2024-06 FY23 finals, 2024-09 H1 24 interim.
  3. Related-party governance flags: CEO loaned the company €1.98m in 2024 then converted £1m at the deeply dilutive 0.55p placing price (versus prior closing prices that were materially higher) 2025-06 FY24 finals, 2025-09 interim. Heavy dilution (~76% in 2025) and director-related debt-equity swaps suggest equity is a financing buffer of last resort.

Operating leverage

The Palm Oil segment has limited operating leverage because the largest cost — fresh-fruit-bunch ("FFB") procurement from smallholders — scales directly with throughput. FY24 cost-of-revenues was €27.2m of which €17.9m (66%) was cost of fruit alone; only depreciation (€3.6m) and overheads (€3.8m) behave as fixed. A 10–20% volume beat at unchanged prices would lift gross margin by maybe €0.5–1.0m and roughly 30–50% of that drops to EBITDA — meaningful in percent terms off a small base, but not "multiples of profit."

The Cashew segment is where the real fixed-cost leverage sits: H1 25 saw RCN processed +269%, sales volumes +126% and the EBITDA loss narrow from €0.9m to €0.2m on €1.5m revenue 2025-09 interim. The mill has 15,000tpa nameplate capacity (vs. ~4,400tpa processed in H1 25 annualised) and management has repeatedly stated capacity can be lifted 50% via a third shift at no incremental capex, then doubled to 30,000tpa for €5–6m capex with implied annual revenue of ~€35m 2023-09 interim, 2022-09 interim. If cashew margins normalise to 10–15% on a fully-utilised mill, this is the segment that could plausibly double or triple group EBITDA from current ~€5–6m run-rate. However, this is contingent on execution that has repeatedly disappointed.

Value-trap signals

  • Working capital deficit of €9.5m persisting across three audit cycles.
  • Going-concern language in FY24 audited accounts referring to "various market conditions… not under the Group's control."
  • Three rounds of debt restructuring with NSIA, BIDC, AgDevCo and (pending) Hudson over 18 months.
  • Capital raise at 0.55p in June 2025 was deeply dilutive (~76% dilution counting CEO debt conversion).
  • Related-party loan from CEO (€1.98m), partially converted to equity at the placing price.
  • Repeated guidance slippage on cashew project across 2022, 2023, 2024 interim and annual reports.
  • Net loss of €3.5m FY24 vs. modest H1 25 break-even — full-year profitability still unproven.
  • Material customer concentration: one customer was 57% of FY24 revenue.

Earnings vs. expectations

Across the period covered the company sets directional rather than numeric guidance. Pattern: palm-oil segment has generally delivered against the qualitative "remains a reliable contributor" line, with EBITDA in a €3.9–4.8m band FY21–FY24; the cashew segment has missed almost every milestone (commercial production "by H2 23", "H2 24", "FY25 first positive EBITDA"). On the H1 25 result the company beat the H1 24 comparable as guided in earlier trading updates. Overall: palm meets, cashew chronically misses, group results have been roughly in line with the company's downbeat re-set expectations since FY23.

Conviction

Conviction: 2 (low). Anchored by clear segment-level disclosure of revenue/EBITDA/volumes and a reasonable historical pattern for the palm-oil business. Limited by (a) extreme balance-sheet fragility making the equity value extremely sensitive to small EBITDA/discount-rate changes, (b) a long track record of cashew execution slippage that makes any FY26+ forecast highly uncertain, and (c) commodity-price exposure where a 10% CPO move materially changes the valuation.

Filings consulted · 25

Every document the LLM read for this note. Click any row to open the source.

  1. 2025-09-262025 Interim Results2025-09-26_9133032_2025-interim-results.md0.77
  2. 2025-09-10Result OF Agm2025-09-10_9099541_result-of-agm.md0.26
  3. 2025-08-15Notice OF Agm2025-08-15_9055052_notice-of-agm.md0.26
  4. 2025-06-302024 Final Results And Financing Update2025-06-30_8953301_2024-final-results-and-financing-update.md0.85
  5. 2024-09-252024 Interim Results2024-09-25_8437130_2024-interim-results.md0.58
  6. 2024-08-12Result OF Agm2024-08-12_8361917_result-of-agm.md0.20
  7. 2024-07-10Half Year Operational Update2024-07-10_8302740_half-year-operational-update.md0.58
  8. 2024-07-09Notice OF Agm2024-07-09_8300431_notice-of-agm.md0.20
  9. 2024-06-282023 Final Results And Financing Update2024-06-28_8285784_2023-final-results-and-financing-update.md0.65
  10. 2023-10-11Investor Presentation And Call2023-10-11_7810280_investor-presentation-and-call.md0.32
  11. 2023-09-282023 Interim Results2023-09-28_7782551_2023-interim-results.md0.41
  12. 2023-07-27Result OF Agm2023-07-27_7658942_result-of-agm.md0.14
  13. 2023-07-12Half Year Operational Update2023-07-12_7627006_half-year-operational-update.md0.41
  14. 2023-06-282022 Final Results And Agm2023-06-28_7599079_2022-final-results-and-agm.md0.45
  15. 2023-01-24Increased Acquisition OF Cashew Operation TO 1002023-01-24_7499582_increased-acquisition-of-cashew-operation-to-100.md0.19
  16. 2022-09-28Investor Presentation Reschedule2022-09-28_7168008_investor-presentation-reschedule.md0.17
  17. 2022-09-22Interim Results And Investor Presentation2022-09-22_7419362_interim-results-and-investor-presentation.md0.23
  18. 2022-07-26Result OF Agm2022-07-26_7137469_result-of-agm.md0.07
  19. 2022-07-26Agm Statement2022-07-26_7136045_agm-statement.md0.10
  20. 2022-06-232021 Final Results2022-06-23_7067233_2021-final-results.md0.25
  21. 2021-09-212021 Interim Results And Shareholder Call2021-09-21_6512409_2021-interim-results-and-shareholder-call.md0.23
  22. 2021-07-15Replacement Half Year Production Update2021-07-15_6653960_replacement-half-year-production-update.md0.23
  23. 2021-07-09Half Year Production Update2021-07-09_6551957_half-year-production-update.md0.23
  24. 2021-07-01Notice OF Agm2021-07-01_6472738_notice-of-agm.md0.07
  25. 2021-06-242020 Final Results2021-06-24_6779868_2020-final-results.md0.25

This research note was authored by a large language model after reading 24 regulatory filings published between 2021-06-24 and 2025-09-26. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.